Antibodies against interferon-beta in multiple sclerosis

Journal of Neuroimmunology

Volumn 212, Issue 1-2, 2009, Pages 148-150

  Aarskog, Nina Karin ^a   Marøy, Tove ^a   Myhr, Kjell Morten ^a,b   Vedeler, Christian A ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

ELISA, Real time PCR; Interferon ; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; NEUTRALIZING ANTIBODY;

ANTIBODY BLOOD LEVEL; ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TREATMENT DURATION;

ANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GTP-BINDING PROTEINS; HUMANS; INTERFERON-BETA; MULTIPLE SCLEROSIS; NEUTRALIZATION TESTS; POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 67649853304     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2009.04.012     Document Type: Article

References (8)

1. Bermel R.A., and Dudick R.A. Interferoñ-β treatment for multiple sclerosis. Neurotherapeutics 4 (2007) 633-646
2. Bertolotto A., Sala A., Caldano M., Capobianco M., Malucchi S., Marnetto F., and Gilli F. Development and validation of real time PCR-based bioassay for quantification of neutralizing antibodies against human interferon-beta. J. Immunol. Methods 321 (2007) 19-31
3. Gilli F., Valentino P., Caldano M., Granieri L., Capobianco M., Malucchi S., Sala A., Marnetto F., and Bertolotto A. Expression and regulation of IFN α/β receptor in IFNβ-treated patients with multiple sclerosis. Neurology 71 (2008) 1-8
4. Gneiss C., Brugger M., Millonig A., Fogdell-Hahn A., Rudzki D., Hillert J., Berger T., Reindl R., and Deisenhammer F. Comparative study of four different assays for the detection of binding antibodies against interferon-β. Mult. Scler. 14 (2008) 830-836
5. Hartung H.-P., Munschauer F., and Schellekens H. Significance of neutralizing antibodies to interferon beta during treatment of multiple sclerosis: expert opinions based on the proceedings of an international consensus conference. Eur. J. Neurol. 12 (2005) 588-601
6. Kawade Y. An analysis of neutralization reaction of interferon by antibody: a proposal on the expression of neutralization titer. J. Interf. Res. 1 (1980) 61-70
7. McKay F., Schibeci S., Heard R., Stewart G., and Booth D. Analysis of neutralizing antibodies to therapeutic interferon-beta in multiple sclerosis patients: a comparison of three methods in a large Australian cohort. J. Immunol. Methods 310 (2006) 20-29
8. Sørensen P.S., Deisenhammer F., Duda P., Hohlfeld R., Myhr K.-M., Palace J., Polman C., Pozzilli C., and Ross C. Guidelines on use of anti-IFN-β antibody measurements in multiple sclerosis: report of an EFNS task force on IFN-β antibodies in multiple sclerosis. Eur. J. Neurol. 12 (2005) 817-827